In the present study, for the first time, a significant decrease in the expression level of the secretory form of clusterin was revealed in pregnant women with placenta accreta, increta, and percreta, compared to pregnant women with a scar on the uterus and/or placenta previa. This evidence concerns the gene CLU and placenta accreta.